Palivizumab prophylaxis in preterm infants

被引：4
|
作者：
Tang, Paul Kiet
机构：
来源：
LANCET RESPIRATORY MEDICINE | 2017年 / 5卷 / 03期
关键词：
D O I：
10.1016/S2213-2600(17)30050-4
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
[No abstract available]
引用
收藏
页码：171 / 171
页数：1
相关论文
共 50 条
  • [1] Appropriateness of Age Thresholds for Palivizumab Prophylaxis in Preterm Infants
    Knox, Caitlin A.
    Hampp, Christian
    Kubilis, Paul S.
    Linden, Stephan
    Winterstein, Almut G.
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2011, 20 : S252 - S252
  • [2] Effect of Palivizumab Prophylaxis on Subsequent Recurrent Wheezing in Preterm Infants
    Yoshihara, Shigemi
    Kusuda, Satoshi
    Mochizuki, Hiroyuki
    Okada, Kenji
    Nishima, Sankei
    Simoes, Eric A. F.
    [J]. PEDIATRICS, 2013, 132 (05) : 811 - 818
  • [3] Precise Gestational Age Definitions Needed for Palivizumab Prophylaxis in Preterm Infants
    Chabra, Shilpi
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197 (05) : 680 - 680
  • [4] Risk factors for recurrent wheezing in preterm infants who received prophylaxis with palivizumab
    Manini, Mariana Bueno
    Matsunaga, Natasha Yumi
    Gianfrancesco, Livea
    Oliveira, Marina Simoes
    Vieira de Carvalho, Maria Rosa
    Martins Tengler Ribeiro, Gisleine Leila
    Morais, Eliane de Oliveira
    Ribeiro, Maria Angela Goncalves O.
    Morcillo, Andre Moreno
    Ribeiro, Jose Dirceu
    Dalbo Contrera Toro, Adyleia Aparecida
    [J]. JORNAL BRASILEIRO DE PNEUMOLOGIA, 2021, 47 (05)
  • [5] Hospitalization for Lower Respiratory Tract Disease in Preterm Infants: Effects of Prophylaxis with Palivizumab
    Faldella, G.
    Alessandroni, R.
    Aquilano, G.
    Vandini, S.
    Lanari, M.
    Silvestri, M.
    Pistorio, A.
    Rossi, G. A.
    [J]. JOURNAL OF CHEMOTHERAPY, 2010, 22 (01) : 30 - 35
  • [6] Palivizumab prophylaxis in 'late preterm' newborns
    Lanari, Marcello
    Silvestri, Michela
    Rossi, Giovanni A.
    [J]. JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE, 2010, 23 : 53 - 55
  • [7] Palivizumab for preterm infants. Is it worth it?
    Embleton, ND
    Harkensee, C
    Mckean, MC
    [J]. ARCHIVES OF DISEASE IN CHILDHOOD-FETAL AND NEONATAL EDITION, 2005, 90 (04): : F286 - F289
  • [8] Cost-effectiveness analysis of palivizumab as respiratory syncytial virus prophylaxis in preterm infants in Sweden
    Neovius, Kristian
    Buesch, Katharina
    Sandstrom, Kristina
    Neovius, Martin
    [J]. ACTA PAEDIATRICA, 2011, 100 (10) : 1306 - 1314
  • [9] Palivizumab Prophylaxis for Healthy Preterm Infants: More Data Supporting American Academy of Pediatrics Guidelines
    Byington, Carrie L.
    Munoz, Flor M.
    [J]. PEDIATRICS, 2016, 138 (02)
  • [10] Risk Factors for Hospitalization due to Lower Respiratory Tract Infection in Preterm Infants on Palivizumab Prophylaxis
    Oncel, Mehmet Yekta
    Arayici, Sema
    Simsek, Gulsum Kadioglu
    Calisici, Erhan
    Erdeve, Omer
    Uras, Nurdan
    Oguz, Serife Suna
    Dilmen, Ugur
    [J]. IRANIAN JOURNAL OF PEDIATRICS, 2013, 23 (06) : 693 - 700
12345